Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Mirum Pharmaceuticals to Present at Investor Conferences in September

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced that the company will present at the following virtual investor conferences in September.

H.C. Wainwright & Co. 22nd Annual Global Investment Conference
September 14-15, 2020
Presentation day and time: Monday, September 14, 2020 at 9:30am ET

Cantor Fitzgerald Virtual Global Healthcare Conference
September 15-17, 2020
Presentation day and time: Thursday, September 17, 2020 at 9:20am ET

A live audio webcast and archive of the presentations will be available in the Investors & Media section of the company website at ir.mirumpharma.com.

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate, maralixibat, is an investigational oral drug in development for Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia. The company has initiated a rolling NDA submission for maralixibat in the treatment of patients with cholestatic pruritus associated with ALGS and expects to complete the submission in the first quarter of 2021. Additionally, the company plans to submit a marketing authorization application to the European Medicines Agency for maralixibat in the treatment of patients with PFIC2 in the fourth quarter 2020.

The company is also developing volixibat, also an oral ASBT-inhibitor, in primary sclerosing cholangitis and intrahepatic cholestasis of pregnancy. For more information, visit MirumPharma.com. Follow Mirum on TwitterFacebook and LinkedIn.

These press releases may also interest you

at 13:35
Today, AmerisourceBergen kicked off its first-ever ThinkLive Trade virtual event, a three-day online summit geared toward brand, specialty and generic manufacturers. The COVID-19 pandemic has tested the resilience of the healthcare industry and...

at 13:35
One of the true marks of someone's expertise, skill, and experience is not simply their ability to do something well, but to help others also do it well. Over the years, Nsenzi Salasini has become one of the world's best digital marketing &...

at 13:30
Lexalytics®, the leader in "words-first" machine learning and artificial intelligence, announced today that it has been recognized as a Representative Vendor in Gartner's August 2020 Market Guide for Text Analytics. Representative Vendors included in...

at 13:25
OncLive® is pleased to announce it has partnered with The Ruesch Center for the Cure of Gastrointestinal (GI) Cancers to host the 11th Annual Ruesch Center Symposium Nov. 20-21. "We are honored to be able to work with The Ruesch Center to help...

at 13:25
The founders of BancKED believe in the power of non-traditional banking and cryptocurrencies for both advancement of financial inclusion for consumers and for boosting brand loyalty for businesses. Yet, they say that businesses too often are not...

at 13:20
Rapid Insight, a leading data analytics software provider, is the Platinum sponsor for the Association of Institutional Research of the Upper Midwest (AIRUM)'s annual conference. The conference is a virtual event exclusively presented for the...

News published on 11 september 2020 at 07:05 and distributed by: